News of the WeekBiomedical Policy

Raising the Stakes in the Race for New Malaria Drugs

See allHide authors and affiliations

Science  25 Sep 1998:
Vol. 281, Issue 5385, pp. 1930-1931
DOI: 10.1126/science.281.5385.1930a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A group of scientists and funders last week gave an initial thumbs-up to a new strategy for bankrolling what could amount to a $30-million-a-year program to develop drugs against malaria, one of the world's biggest scourges. Although details are still being worked out, drug company representatives and potential donors--who gathered at a closed-door meeting on 17 September at the Rockefeller Foundation in New York City--believe they have overcome key hurdles that undermined a similar effort last November.